Top Markets
Coin of the day
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc.

MLND
Rank in Stocks #40617
Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to... Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to developing innovative therapies for rare hormonal disorders, primarily within the United States. The company's key therapeutic candidates include livoletide, an investigational drug aimed at Prader-Willi syndrome; nevanimibe, an experimental compound designed for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist intended to alleviate vasomotor symptoms (such as hot flashes) in women experiencing menopause. This enterprise maintains its primary operational base in Ann Arbor, Michigan.
Share Price
$1.06
Last synced: 2021-06-25
Market Cap
$110.93K
Change (1 day)
-5.36%
Change (1 year)
0.00%
Country
US
Trade Millendo Therapeutics, Inc. (MLND)

Category

Price of MLND with the market cap of B
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
MLND
$1.06
Market Capitalization of Millendo Therapeutics, Inc.(MLND)
Market Cap: $110.93K
As of August 2026 Millendo Therapeutics, Inc. has a market cap of $110.93K. This makes Millendo Therapeutics, Inc. the world's 40617th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Millendo Therapeutics, Inc. from 2018 to 2026
MLND compared with Top 5 Most Popular stocks
Price of MLND Asset B Mkt. of B Results
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$52,210,467 $110.93K
$5.464T +4,925,515,671.77%
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$42,580,406 $110.93K
$4.456T +4,017,019,360.42%
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$39,891,725 $110.93K
$4.175T +3,763,370,142.40%
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$35,025,657 $110.93K
$3.665T +3,304,307,141.93%
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$27,253,294 $110.93K
$2.852T +2,571,065,334.91%